Morgan Stanley’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.21M | Buy |
1,037,153
+37,316
| +4% | +$259K | ﹤0.01% | 3752 |
|
2025
Q1 | $8.49M | Buy |
999,837
+137,700
| +16% | +$1.17M | ﹤0.01% | 3490 |
|
2024
Q4 | $12.1M | Sell |
862,137
-487,757
| -36% | -$6.83M | ﹤0.01% | 3254 |
|
2024
Q3 | $30.5M | Buy |
1,349,894
+118,321
| +10% | +$2.68M | ﹤0.01% | 2356 |
|
2024
Q2 | $24.9M | Sell |
1,231,573
-285,142
| -19% | -$5.77M | ﹤0.01% | 2429 |
|
2024
Q1 | $37.8M | Sell |
1,516,715
-541,735
| -26% | -$13.5M | ﹤0.01% | 2030 |
|
2023
Q4 | $37.2M | Buy |
2,058,450
+436,701
| +27% | +$7.9M | ﹤0.01% | 2758 |
|
2023
Q3 | $32.6M | Buy |
1,621,749
+182,182
| +13% | +$3.66M | ﹤0.01% | 1972 |
|
2023
Q2 | $36.7M | Sell |
1,439,567
-68,182
| -5% | -$1.74M | ﹤0.01% | 1878 |
|
2023
Q1 | $32.1M | Buy |
1,507,749
+786,190
| +109% | +$16.7M | ﹤0.01% | 1942 |
|
2022
Q4 | $21.4M | Sell |
721,559
-138,292
| -16% | -$4.09M | ﹤0.01% | 2272 |
|
2022
Q3 | $20M | Buy |
859,851
+38,647
| +5% | +$899K | ﹤0.01% | 2192 |
|
2022
Q2 | $13.8M | Buy |
821,204
+733,287
| +834% | +$12.3M | ﹤0.01% | 2703 |
|
2022
Q1 | $3.86M | Sell |
87,917
-62,095
| -41% | -$2.72M | ﹤0.01% | 3958 |
|
2021
Q4 | $9.13M | Buy |
150,012
+5,399
| +4% | +$329K | ﹤0.01% | 3041 |
|
2021
Q3 | $6.02M | Buy |
144,613
+78,407
| +118% | +$3.26M | ﹤0.01% | 3476 |
|
2021
Q2 | $2.01M | Buy |
66,206
+63,966
| +2,856% | +$1.94M | ﹤0.01% | 4627 |
|
2021
Q1 | $67K | Sell |
2,240
-1,232
| -35% | -$36.9K | ﹤0.01% | 6209 |
|
2020
Q4 | $62K | Sell |
3,472
-517
| -13% | -$9.23K | ﹤0.01% | 6087 |
|
2020
Q3 | $76K | Buy |
3,989
+515
| +15% | +$9.81K | ﹤0.01% | 5546 |
|
2020
Q2 | $55K | Buy |
3,474
+219
| +7% | +$3.47K | ﹤0.01% | 5645 |
|
2020
Q1 | $44K | Buy |
3,255
+3,245
| +32,450% | +$43.9K | ﹤0.01% | 5509 |
|
2019
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6644 |
|